Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06003621 |
Title | Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients (MoST-TAP) |
Acronym | MoST-TAP |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Omico |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | AUS |